🟢 GT Biopharma is trading 12.05% up today amid speculative post-split activity

GT Biopharma is trading $6.70 (+12.05%) amid continued speculative post-split activity.

• The September 8, 2026, 1-for-25 reverse stock split reduced outstanding shares from roughly 45.1 million to 1.8 million.
• The split was intended to support continued Nasdaq trading.
• No new September 10 company announcement was found.